UGT1A3
Basic information
Region (hg38): 2:233729042-233773300
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (22 variants)
- Crigler-Najjar syndrome type 1 (6 variants)
- Crigler-Najjar syndrome (4 variants)
- UGT1A1-related disorder (4 variants)
- Hyperbilirubinemia (2 variants)
- Gilbert syndrome (2 variants)
- Crigler-Najjar syndrome, type II (2 variants)
- Crigler-Najjar syndrome type 1;Gilbert syndrome;Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT1A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 25 | ||||
missense | 69 | 83 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 15 | 11 | 84 | 24 | 12 | 146 |
Total | 26 | 23 | 162 | 47 | 12 |
Highest pathogenic variant AF is 0.0000919
Variants in UGT1A3
This is a list of pathogenic ClinVar variants found in the UGT1A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-233729061-T-C | Levothyroxine response | other (-) | ||
2-233729155-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
2-233729257-T-A | not specified | Uncertain significance (May 24, 2023) | ||
2-233729361-A-T | not specified | Uncertain significance (Feb 17, 2023) | ||
2-233729401-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
2-233729401-A-T | not specified | Likely benign (Dec 06, 2021) | ||
2-233729424-T-C | not specified | Uncertain significance (Dec 13, 2022) | ||
2-233729464-G-C | not specified | Likely benign (Feb 12, 2024) | ||
2-233729472-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
2-233729506-C-G | not specified | Uncertain significance (May 30, 2024) | ||
2-233729522-A-G | Likely benign (Feb 01, 2024) | |||
2-233729562-T-C | not specified | Uncertain significance (Mar 26, 2024) | ||
2-233729598-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
2-233729599-C-T | Likely benign (Jul 16, 2018) | |||
2-233729793-A-G | not specified | Uncertain significance (Nov 12, 2021) | ||
2-233729811-G-C | Uncertain significance (Aug 09, 2019) | |||
2-233729930-A-G | Likely benign (Sep 01, 2022) | |||
2-233729945-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
2-233729953-T-C | not specified | Uncertain significance (Sep 08, 2023) | ||
2-233729976-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
2-233743483-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
2-233743531-A-T | not specified | Uncertain significance (Sep 16, 2021) | ||
2-233743622-C-T | Benign (Apr 04, 2018) | |||
2-233743834-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
2-233756997-A-G | UGT1A1-related disorder | Likely benign (Sep 21, 2021) |
GnomAD
Source:
dbNSFP
Source: